StemSight Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$351K
- Investors
-
13
StemSight General Information
Description
Developer of an off-the-shelf cell therapy platform designed to treat blindness. The company's platform treats cells based on induced pluripotent stem cells (iPSCs) and biomaterials, and it aims to enter the market with a first-in-class therapy for a rare disease, limbal stem cell deficiency, later expanding to major forms of corneal blindness, enabling patients with corneal blindness to regain their vision.
Contact Information
Website
www.stemsight.fiCorporate Office
- Finn-Medi 5, 6th floor
- Biokatu 12
- 33520 Tampere
- Finland
Corporate Office
- Finn-Medi 5, 6th floor
- Biokatu 12
- 33520 Tampere
- Finland
StemSight Timeline
StemSight Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Early Stage VC | 30-Apr-2026 | $351K | Completed | Startup | ||
| 13. Accelerator/Incubator | 12-Feb-2026 | Completed | Startup | |||
| 12. Grant | 01-Jan-2025 | Completed | Startup | |||
| 11. Accelerator/Incubator | 01-Jan-2025 | Completed | Pre-Clinical Trials | |||
| 10. Early Stage VC | 22-Nov-2024 | Completed | Pre-Clinical Trials | |||
| 9. Accelerator/Incubator | 01-Jan-2024 | Completed | Pre-Clinical Trials | |||
| 8. Grant | 21-Jun-2023 | Completed | Startup | |||
| 7. Accelerator/Incubator | 09-Jun-2023 | Completed | Startup | |||
| 6. Accelerator/Incubator | 01-Apr-2023 | $80.4K | $672K | Completed | Startup | |
| 5. Grant | 15-Mar-2022 | $55.7K | $591K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
StemSight Comparisons
Industry
Financing
Details
StemSight Competitors (3)
One of StemSight’s 3 competitors is Cellusion, a Venture Capital-Backed company based in Tokyo, Japan.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cellusion | Venture Capital-Backed | Tokyo, Japan | ||||
| Aurion Biotech | Formerly VC-backed | Seattle, WA | ||||
| Claris Bio | Venture Capital-Backed | Half Moon Bay, CA |
StemSight Patents
StemSight Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3192264-A1 | Method for differentiating corneal endothelial cell-like cells from pluripotent stem cells | Pending | 03-Sep-2020 | ||
| EP-4208539-A1 | Method for differentiating corneal endothelial cell-like cells from pluripotent stem cells | Pending | 03-Sep-2020 | ||
| US-20230392116-A1 | Method for differentiating corneal endothelial cell-like cells from pluripotent stem cells | Pending | 03-Sep-2020 | ||
| WO-2022049328-A1 | Method for differentiating corneal endothelial cell-like cells from pluripotent stem cells | Inactive | 03-Sep-2020 | ||
| JP-2026067912-A | Method for obtaining or maintaining abcg2 positive limbal stem cells | Pending | 01-Apr-2019 | C12N5/0621 |
StemSight Signals
StemSight Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Japan External Trade Organization | Accelerator/Incubator | |||
| Biothom | Venture Capital | Minority | ||
| Stephen Industries | Venture Capital | Minority | ||
| Nordic Mentor Network For Entrepreneurship | Accelerator/Incubator | Minority | ||
| European Commission | Government |
StemSight FAQs
-
When was StemSight founded?
StemSight was founded in 2021.
-
Where is StemSight headquartered?
StemSight is headquartered in Tampere, Finland.
-
What is the size of StemSight?
StemSight has 10 total employees.
-
What industry is StemSight in?
StemSight’s primary industry is Biotechnology.
-
Is StemSight a private or public company?
StemSight is a Private company.
-
What is the current valuation of StemSight?
The current valuation of StemSight is .
-
What is StemSight’s current revenue?
The current revenue for StemSight is .
-
How much funding has StemSight raised over time?
StemSight has raised $3.92M.
-
Who are StemSight’s investors?
Japan External Trade Organization, Biothom, Stephen Industries, Nordic Mentor Network For Entrepreneurship, and European Commission are 5 of 13 investors who have invested in StemSight.
-
Who are StemSight’s competitors?
Cellusion, Aurion Biotech, and Claris Bio are competitors of StemSight.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process